These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 30413160
21. CSF1 overexpression has pleiotropic effects on microglia in vivo. De I, Nikodemova M, Steffen MD, Sokn E, Maklakova VI, Watters JJ, Collier LS. Glia; 2014 Dec; 62(12):1955-67. PubMed ID: 25042473 [Abstract] [Full Text] [Related]
22. A limited capacity for microglial repopulation in the adult brain. Najafi AR, Crapser J, Jiang S, Ng W, Mortazavi A, West BL, Green KN. Glia; 2018 Nov; 66(11):2385-2396. PubMed ID: 30370589 [Abstract] [Full Text] [Related]
24. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D. Brain; 2016 Mar 18; 139(Pt 3):891-907. PubMed ID: 26747862 [Abstract] [Full Text] [Related]
25. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model. van Olst L, Verhaege D, Franssen M, Kamermans A, Roucourt B, Carmans S, Ytebrouck E, van der Pol SMA, Wever D, Popovic M, Vandenbroucke RE, Sobrino T, Schouten M, de Vries HE. Neurobiol Aging; 2020 May 18; 89():89-98. PubMed ID: 32008854 [Abstract] [Full Text] [Related]
26. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monzón-Sandoval J, Ribe E, Winchester L, Webber C, Nevado A, Jacobs T, Austin N, Theunis C, Grauwen K, Daniela Ruiz E, Mudher A, Vicente-Rodriguez M, Parker CA, Simmons C, Cash D, Richardson J, NIMA Consortium, Jones DNC, Lovestone S, Gómez-Nicola D, Perry VH. Brain; 2019 Oct 01; 142(10):3243-3264. PubMed ID: 31504240 [Abstract] [Full Text] [Related]
27. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S, Ji B, Zhang MR, Aoki I, Suhara T, Higuchi M, Sahara N. J Alzheimers Dis; 2018 Oct 01; 61(3):1037-1052. PubMed ID: 29332041 [Abstract] [Full Text] [Related]
28. CSF1R inhibitor PLX3397 depletes microglia in Mongolian gerbil Meriones unguiculatus, but not in syrian hamster Mesocricetus auratus. Sato RY, Zhang Y, Kotake KT, Onishi H, Ito S, Norimoto H, Zhou Z. J Pharmacol Sci; 2024 Jun 01; 155(2):29-34. PubMed ID: 38677783 [Abstract] [Full Text] [Related]
29. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex. Zhang B, Zou J, Han L, Rensing N, Wong M. Epilepsia; 2016 Aug 01; 57(8):1317-25. PubMed ID: 27263494 [Abstract] [Full Text] [Related]
30. Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain. Taetzsch T, Benusa S, Levesque S, Mumaw CL, Block ML. J Neuroinflammation; 2019 Mar 12; 16(1):60. PubMed ID: 30871598 [Abstract] [Full Text] [Related]
31. Switch to phagocytic microglia by CSFR1 inhibition drives amyloid-beta clearance from glutamatergic terminals rescuing LTP in acute hippocampal slices. Piccioni G, Maisto N, d'Ettorre A, Strimpakos G, Nisticò R, Triaca V, Mango D. Transl Psychiatry; 2024 Aug 23; 14(1):338. PubMed ID: 39179543 [Abstract] [Full Text] [Related]
32. Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine. da Silva MCM, Gomes GF, de Barros Fernandes H, da Silva AM, Teixeira AL, Moreira FA, de Miranda AS, de Oliveira ACP. Sci Rep; 2021 Aug 06; 11(1):15989. PubMed ID: 34362959 [Abstract] [Full Text] [Related]
33. Absence of microglia or presence of peripherally-derived macrophages does not affect tau pathology in young or old hTau mice. Zhu K, Pieber M, Han J, Blomgren K, Zhang XM, Harris RA, Lund H. Glia; 2020 Jul 06; 68(7):1466-1478. PubMed ID: 32039516 [Abstract] [Full Text] [Related]
34. Dynamic changes in microglia in the mouse hippocampus during administration and withdrawal of the CSF1R inhibitor PLX3397. Wang Q, Wang YY, Pu WJ, Ma X, Ni RJ. J Anat; 2023 Sep 06; 243(3):394-403. PubMed ID: 37038887 [Abstract] [Full Text] [Related]
35. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model. Wang H, Li Y, Ryder JW, Hole JT, Ebert PJ, Airey DC, Qian HR, Logsdon B, Fisher A, Ahmed Z, Murray TK, Cavallini A, Bose S, Eastwood BJ, Collier DA, Dage JL, Miller BB, Merchant KM, O'Neill MJ, Demattos RB. Mol Neurodegener; 2018 Dec 17; 13(1):65. PubMed ID: 30558641 [Abstract] [Full Text] [Related]
36. S100A8-enriched microglia populate the brain of tau-seeded and accelerated aging mice. Gruel R, Bijnens B, Van Den Daele J, Thys S, Willems R, Wuyts D, Van Dam D, Verstraelen P, Verboven R, Roels J, Vandamme N, Mancuso R, Pita-Almenar JD, De Vos WH. Aging Cell; 2024 May 17; 23(5):e14120. PubMed ID: 38403918 [Abstract] [Full Text] [Related]
37. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model. Zhang D, Li S, Hou L, Jing L, Ruan Z, Peng B, Zhang X, Hong JS, Zhao J, Wang Q. J Neuroinflammation; 2021 Jan 05; 18(1):4. PubMed ID: 33402167 [Abstract] [Full Text] [Related]
38. Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage. Li M, Li Z, Ren H, Jin WN, Wood K, Liu Q, Sheth KN, Shi FD. J Cereb Blood Flow Metab; 2017 Jul 05; 37(7):2383-2395. PubMed ID: 27596835 [Abstract] [Full Text] [Related]
39. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Jiang T, Zhang YD, Chen Q, Gao Q, Zhu XC, Zhou JS, Shi JQ, Lu H, Tan L, Yu JT. Neuropharmacology; 2016 Jun 05; 105():196-206. PubMed ID: 26802771 [Abstract] [Full Text] [Related]